45 studies found for:    Open Studies | "Keratosis, Actinic"
Show Display Options
Rank Status Study
21 Recruiting Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest
Condition: Actinic Keratosis
Intervention: Drug: Ingenol Mebutate
22 Recruiting Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively
Condition: Actinic Keratosis
Intervention: Drug: LEO 43204
23 Recruiting Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses
Condition: Actinic Keratoses
Interventions: Drug: Ingenol Mebutate;   Procedure: Cryotherapy
24 Recruiting Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic Keratoses
Condition: Actinic Keratosis
Interventions: Procedure: Pretreatment with CO2 laser before photodynamic therapy;   Device: Only photodynamic therapy
25 Not yet recruiting Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
Condition: Actinic Keratosis (AK)
Interventions: Drug: Ingenol Mebutate Gel, 0.015%;   Drug: Diclofenac sodium gel 3%
26 Not yet recruiting MUSE Study of Levulan Kerastick
Condition: Keratosis, Actinic
Interventions: Drug: Aminolevulinic Acid  (ALA);   Device: BLU-U
27 Unknown  Fractional CO2 Laser Assisted Photodynamic Therapy
Conditions: Actinic Keratosis;   Basal Cell Carcinoma
Interventions: Drug: Conventional photodynamic therapy;   Drug: Fractional CO2 laser assisted PDT
28 Recruiting Twelve Month Follow-Up of CP0108
Condition: Actinic Keratosis
Interventions: Drug: Aminolevulinic Acid (ALA);   Drug: Topical Solution Vehicle;   Device: BLU-U Blue Light Photodynamic Therapy Illuminator
29 Recruiting Actinic Keratosis Study
Condition: Actinic Keratosis
Interventions: Drug: 5-fluorouracil 5% cream;   Drug: Calcipotriol 0.005% ointment;   Drug: Vaseline
30 Recruiting To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Ingenol Mebutate (Perrigo);   Drug: Ingenol Mebutate (Reference);   Drug: Placebo gel
31 Recruiting Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
Condition: Actinic Keratosis (AK)
Interventions: Drug: Ingenol Mebutate Gel, 0.015%;   Drug: Imiquimod Cream, 5%
32 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
33 Recruiting PMS to Evaluate the Safety and Efficacy of Picato® Gel
Condition: Actinic Keratosis
Intervention: Drug: Ingenol mebutate 0.015 percent or 0.05 percent gel
34 Unknown  5fluorouracil for Advanced Photoaging
Conditions: Photoaging;   Actinic Keratosis
Interventions: Drug: 5-fluoruracil;   Procedure: 5-fluoruracil
35 Recruiting A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
Condition: Actinic Keratoses
Interventions: Drug: Antihistamine Cetirizine Hydrochloride;   Other: Placebo
36 Not yet recruiting Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Conditions: Extensive Photodamage;   Actinic Keratosis;   History of Numerous Skin Cancers
Interventions: Device: Ultrapulse Carbon Dioxide Laser;   Device: Cellutome epidermal harvesting system
37 Not yet recruiting Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis
Condition: Chronic Arsenic Poisoning
Interventions: Drug: Neem plus propylene glycol plus salicylic acid;   Drug: Salicylic acid
38 Recruiting Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Conditions: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue;   Pyoderma Gangrenosum;   Erosive Pustular Dermatosis of the Scalp;   Sweet's Syndrome;   Behcet's Disease;   Bowel-associated Dermatosis-arthritis Syndrome;   Pustular Psoriasis;   Acute Generalized Exanthematous Pustulosis;   Keratoderma Blenorrhagicum;   Sneddon-Wilkinson Disease;   IgA Pemphigus;   Amicrobial Pustulosis of the Folds;   Infantile Acropustulosis;   Transient Neonatal Pustulosis;   Neutrophilic Eccrine Hidradenitis;   Rheumatoid Neutrophilic Dermatitis;   Neutrophilic Urticaria;   Still's Disease;   Erythema Marginatum;   Unclassified Periodic Fever Syndromes / Autoinflammatory Syndromes;   Dermatitis Herpetiformis;   Linear IgA Bullous Dermatosis;   Bullous Systemic Lupus Erythematosus;   Inflammatory Epidermolysis Bullosa Aquisita;   Neutrophilic Dermatosis of the Dorsal Hands (Pustular Vasculitis);   Small Vessel Vasculitis Including Urticarial Vasculitis;   Erythema Elevatum Diutinum;   Medium Vessel Vasculitis
Intervention: Procedure: Collection of biological samples
39 Not yet recruiting Gene Therapy for Netherton Syndrome
Condition: Netherton Syndrome
Intervention: Genetic: One 20cm2/10cm2 autologous skin sheet graft
40 Recruiting A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
Condition: Sjögren-Larsson Syndrome
Interventions: Drug: Active topical NS2 1% dermatologic cream;   Drug: Vehicle placebo 0.0% NS2 dermatologic cream

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Indicates status has not been verified in more than two years